« Investing in RSuite CMS: A four month ROI | Main | RSuite conference - business takeaway »

November 03, 2008

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83453675c69e2010535cea173970b

Listed below are links to weblogs that reference DITA: It's Just XML:

Comments

Bob DuCharme

Hi Eliot,

For "commercial tools [to] 'just work' with your content with little or no additional configuration, regardless of how custom your tags are" you must take advantage of specialization, but it seems to me that lot of people go on about the benefits of DITA without really understanding this, thereby taking the "just XML" bit a little too far--they're pushing many benefits of DITA that have been around since SGML DocBook (more on this here).

For example, note how Madcap software goes on and on about their DITA support, but how this shows that the word "specialization" doesn't appear anywhere on their website. (They have not responded to a 10/30 email asking about specialization support.) I was also surprised at how the CMSWatch "XML & Component Content Report 2008" (plugged by Bob Glushko here) described DITA specialization in terms that made it sound no different from the customizability of DocBook or XHTML 1.1, missing the point you bring up that DITA lets you process customized content with software that knows nothing about the customization.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Our Company